Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02864862 · ClinicalTrials.gov registry record · Phase 4
Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT02864862 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 46 participants.
The verdict
NCT02864862, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.
Interventions
- DEVICE Immediate implant
- BIOLOGICAL SCTG
- BIOLOGICAL ADM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-10 |
| Est. Completion | 2021-11-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02864862
The ClinicalTrials.gov registry entry for NCT02864862 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Immediate implant is the first listed.
NCT02864862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02864862 about?
NCT02864862 is a clinical study titled "Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation". The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.
What is the current status of trial NCT02864862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2016-10. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT02864862?
The interventions under investigation include: Immediate implant (DEVICE), SCTG (BIOLOGICAL), ADM (BIOLOGICAL).
Who is sponsoring clinical trial NCT02864862?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.